Research2Guidance March 28, 2024
PHTI’s recent report is rubbing salt into the wound. But as the report’s limitations surface, ROI for the customers of digital diabetes solutions comes under scrutiny. Vendors must make their ROI statements more transparent. Diversification strategies for digital diabetes businesses become an essential lever.
The recent report published by PHTI argues that digital diabetes management solutions are not living up to their promises regarding cost savings and long-term health outcomes. The report took a look at 8 digital health companies with Type 2 diabetes (T2D) management services, including DarioHealth, Omada Health, Glooko, Perry Health, Livongo by Teladoc, Onduo by Verily, Virta Health, and Vida Health, and scrutinized the clinical evidence and health economic outcomes of their solutions for T2D management.
...Today's Sponsors
Today's Sponsor